Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 148

1.

Repurposing tin mesoporphyrin as an immune checkpoint inhibitor shows therapeutic efficacy in preclinical models of cancer.

Muliaditan T, Opzoomer JW, Caron J, Okesola M, Kosti P, Lall S, Van Hemelrijck M, Dazzi F, Tutt A, Grigoriadis A, Gillett C, Madden SF, Burchell JM, Kordasti S, Diebold SS, Spicer J, Arnold JN.

Clin Cancer Res. 2018 Jan 16. pii: clincanres.2587.2017. doi: 10.1158/1078-0432.CCR-17-2587. [Epub ahead of print]

PMID:
29339440
2.

Correction: Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.

Hadjialirezaei S, Picco G, Beatson R, Burchell J, Stokke BT, Sletmoen M.

PLoS One. 2018 Jan 2;13(1):e0190814. doi: 10.1371/journal.pone.0190814. eCollection 2018.

3.

Comparative Effectiveness of Routine Invasive Coronary Angiography for Managing Unstable Angina.

Vogrin S, Harper R, Paratz E, MacIsaac A, Burchell J, Smith B, Scott A, Yong J, Sundararajan V.

Ann Intern Med. 2017 Jun 6;166(11):783-791. doi: 10.7326/M16-2420. Epub 2017 May 2.

PMID:
28462421
4.

Interactions between the breast cancer-associated MUC1 mucins and C-type lectin characterized by optical tweezers.

Hadjialirezaei S, Picco G, Beatson R, Burchell J, Stokke BT, Sletmoen M.

PLoS One. 2017 Apr 17;12(4):e0175323. doi: 10.1371/journal.pone.0175323. eCollection 2017. Erratum in: PLoS One. 2018 Jan 2;13(1):e0190814.

5.

Whole-genome analysis of mycobacteria from birds at the San Diego Zoo.

Pfeiffer W, Braun J, Burchell J, Witte CL, Rideout BA.

PLoS One. 2017 Mar 7;12(3):e0173464. doi: 10.1371/journal.pone.0173464. eCollection 2017.

6.

JARID1/KDM5 demethylases as cancer targets?

Taylor-Papadimitriou J, Burchell J.

Expert Opin Ther Targets. 2017 Jan;21(1):5-7. Epub 2016 Nov 28. No abstract available.

PMID:
27882807
7.

Targeting of Tumor-Associated Glycoforms of MUC1 with CAR T Cells.

Maher J, Wilkie S, Davies DM, Arif S, Picco G, Julien S, Foster J, Burchell J, Taylor-Papadimitriou J.

Immunity. 2016 Nov 15;45(5):945-946. doi: 10.1016/j.immuni.2016.10.014.

8.

The mucin MUC1 modulates the tumor immunological microenvironment through engagement of the lectin Siglec-9.

Beatson R, Tajadura-Ortega V, Achkova D, Picco G, Tsourouktsoglou TD, Klausing S, Hillier M, Maher J, Noll T, Crocker PR, Taylor-Papadimitriou J, Burchell JM.

Nat Immunol. 2016 Nov;17(11):1273-1281. doi: 10.1038/ni.3552. Epub 2016 Sep 5.

9.

Prion diseases: immunotargets and therapy.

Burchell JT, Panegyres PK.

Immunotargets Ther. 2016 Jun 16;5:57-68. doi: 10.2147/ITT.S64795. eCollection 2016. Review.

10.

Toll-like Receptor Expression and Signaling in Peripheral Blood Mononuclear Cells Correlate With Clinical Outcomes in Acute Hepatitis C Virus Infection.

Chen Yi Mei SL, Burchell J, Skinner N, Millen R, Matthews G, Hellard M, Dore GJ, Desmond PV, Sundararajan V, Thompson AJ, Visvanathan K, Sasadeusz J.

J Infect Dis. 2016 Sep 1;214(5):739-47. doi: 10.1093/infdis/jiw235. Epub 2016 Jun 9.

11.

Interactions of mucins with the Tn or Sialyl Tn cancer antigens including MUC1 are due to GalNAc-GalNAc interactions.

Haugstad KE, Hadjialirezaei S, Stokke BT, Brewer CF, Gerken TA, Burchell J, Picco G, Sletmoen M.

Glycobiology. 2016 Dec;26(12):1338-1350. Epub 2016 Jun 9.

12.

Two E-selectin ligands, BST-2 and LGALS3BP, predict metastasis and poor survival of ER-negative breast cancer.

Woodman N, Pinder SE, Tajadura V, Le Bourhis X, Gillett C, Delannoy P, Burchell JM, Julien S.

Int J Oncol. 2016 Jul;49(1):265-75. doi: 10.3892/ijo.2016.3521. Epub 2016 May 13.

PMID:
27176937
13.

Selection of a Relevant In Vitro Blood-Brain Barrier Model to Investigate Pro-Metastatic Features of Human Breast Cancer Cell Lines.

Drolez A, Vandenhaute E, Julien S, Gosselet F, Burchell J, Cecchelli R, Delannoy P, Dehouck MP, Mysiorek C.

PLoS One. 2016 Mar 9;11(3):e0151155. doi: 10.1371/journal.pone.0151155. eCollection 2016.

14.

Individualised mindfulness-based stress reduction for head and neck cancer patients undergoing radiotherapy of curative intent: a descriptive pilot study.

Pollard A, Burchell JL, Castle D, Neilson K, Ftanou M, Corry J, Rischin D, Kissane DW, Krishnasamy M, Carlson LE, Couper J.

Eur J Cancer Care (Engl). 2017 Mar;26(2). doi: 10.1111/ecc.12474. Epub 2016 Mar 7.

PMID:
26947583
15.

Early Dementia Screening.

Panegyres PK, Berry R, Burchell J.

Diagnostics (Basel). 2016 Jan 21;6(1). pii: E6. doi: 10.3390/diagnostics6010006. Review.

16.

Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanoma.

Karagiannis P, Villanova F, Josephs DH, Correa I, Van Hemelrijck M, Hobbs C, Saul L, Egbuniwe IU, Tosi I, Ilieva KM, Kent E, Calonje E, Harries M, Fentiman I, Taylor-Papadimitriou J, Burchell J, Spicer JF, Lacy KE, Nestle FO, Karagiannis SN.

Oncoimmunology. 2015 Jun 3;4(11):e1032492. eCollection 2015 Nov.

17.

Regulator of G protein signaling 5 is a determinant of gestational hypertension and preeclampsia.

Holobotovskyy V, Chong YS, Burchell J, He B, Phillips M, Leader L, Murphy TV, Sandow SL, McKitrick DJ, Charles AK, Tare M, Arnolda LF, Ganss R.

Sci Transl Med. 2015 Jun 3;7(290):290ra88. doi: 10.1126/scitranslmed.aaa5038.

PMID:
26041705
18.

The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL.

Beatson R, Maurstad G, Picco G, Arulappu A, Coleman J, Wandell HH, Clausen H, Mandel U, Taylor-Papadimitriou J, Sletmoen M, Burchell JM.

PLoS One. 2015 May 7;10(5):e0125994. doi: 10.1371/journal.pone.0125994. eCollection 2015.

19.

Predicting distress among people who care for patients living longer with high-grade malignant glioma.

Russell B, Collins A, Dowling A, Dally M, Gold M, Murphy M, Burchell J, Philip J.

Support Care Cancer. 2016 Jan;24(1):43-51. doi: 10.1007/s00520-015-2739-0. Epub 2015 Apr 25.

PMID:
25910750
20.

Models of breast morphogenesis based on localization of stem cells in the developing mammary lobule.

Honeth G, Schiavinotto T, Vaggi F, Marlow R, Kanno T, Shinomiya I, Lombardi S, Buchupalli B, Graham R, Gazinska P, Ramalingam V, Burchell J, Purushotham AD, Pinder SE, Csikasz-Nagy A, Dontu G.

Stem Cell Reports. 2015 Apr 14;4(4):699-711. doi: 10.1016/j.stemcr.2015.02.013. Epub 2015 Mar 26.

21.

Isolation of a Bohle-like iridovirus from boreal toads housed within a cosmopolitan aquarium collection.

Cheng K, Jones ME, Jancovich JK, Burchell J, Schrenzel MD, Reavill DR, Imai DM, Urban A, Kirkendall M, Woods LW, Chinchar VG, Pessier AP.

Dis Aquat Organ. 2014 Sep 30;111(2):139-52. doi: 10.3354/dao02770.

22.

Molecular methods to detect Mycoplasma spp. And Testudinid herpesvirus 2 in desert tortoises (Gopherus agassizii) and implications for disease management.

Braun J, Schrenzel M, Witte C, Gokool L, Burchell J, Rideout BA.

J Wildl Dis. 2014 Oct;50(4):757-66. doi: 10.7589/2013-09-231. Epub 2014 Aug 14.

PMID:
25121400
23.

Growth hormone is secreted by normal breast epithelium upon progesterone stimulation and increases proliferation of stem/progenitor cells.

Lombardi S, Honeth G, Ginestier C, Shinomiya I, Marlow R, Buchupalli B, Gazinska P, Brown J, Catchpole S, Liu S, Barkan A, Wicha M, Purushotham A, Burchell J, Pinder S, Dontu G.

Stem Cell Reports. 2014 Jun 3;2(6):780-93. doi: 10.1016/j.stemcr.2014.05.005. eCollection 2014 Jun 3.

24.

Microvesicle cargo of tumor-associated MUC1 to dendritic cells allows cross-presentation and specific carbohydrate processing.

Rughetti A, Rahimi H, Belleudi F, Napoletano C, Battisti F, Zizzari IG, Antonilli M, Bellati F, Wandall HH, Benedetti Panici P, Burchell JM, Torrisi MR, Nuti M.

Cancer Immunol Res. 2014 Feb;2(2):177-86. doi: 10.1158/2326-6066.CIR-13-0112-T. Epub 2013 Oct 28.

25.

Targeting DNGR-1 (CLEC9A) with antibody/MUC1 peptide conjugates as a vaccine for carcinomas.

Picco G, Beatson R, Taylor-Papadimitriou J, Burchell JM.

Eur J Immunol. 2014 Jul;44(7):1947-55. doi: 10.1002/eji.201344076. Epub 2014 Apr 17.

26.

Accurate measurements of frontal analysis for the determination of adsorption isotherms in supercritical fluid chromatography.

Kamarei F, Gritti F, Guiochon G, Burchell J.

J Chromatogr A. 2014 Feb 14;1329:71-7. doi: 10.1016/j.chroma.2013.12.033. Epub 2014 Jan 8.

PMID:
24456708
27.

Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.

Eccles SA, Aboagye EO, Ali S, Anderson AS, Armes J, Berditchevski F, Blaydes JP, Brennan K, Brown NJ, Bryant HE, Bundred NJ, Burchell JM, Campbell AM, Carroll JS, Clarke RB, Coles CE, Cook GJ, Cox A, Curtin NJ, Dekker LV, Silva Idos S, Duffy SW, Easton DF, Eccles DM, Edwards DR, Edwards J, Evans D, Fenlon DF, Flanagan JM, Foster C, Gallagher WM, Garcia-Closas M, Gee JM, Gescher AJ, Goh V, Groves AM, Harvey AJ, Harvie M, Hennessy BT, Hiscox S, Holen I, Howell SJ, Howell A, Hubbard G, Hulbert-Williams N, Hunter MS, Jasani B, Jones LJ, Key TJ, Kirwan CC, Kong A, Kunkler IH, Langdon SP, Leach MO, Mann DJ, Marshall JF, Martin L, Martin SG, Macdougall JE, Miles DW, Miller WR, Morris JR, Moss SM, Mullan P, Natrajan R, O'Connor JP, O'Connor R, Palmieri C, Pharoah PD, Rakha EA, Reed E, Robinson SP, Sahai E, Saxton JM, Schmid P, Smalley MJ, Speirs V, Stein R, Stingl J, Streuli CH, Tutt AN, Velikova G, Walker RA, Watson CJ, Williams KJ, Young LS, Thompson AM.

Breast Cancer Res. 2013 Oct 1;15(5):R92. doi: 10.1186/bcr3493. Review.

28.

Cancer-associated autoantibodies to MUC1 and MUC4--a blinded case–control study of colorectal cancer in UK collaborative trial of ovarian cancer screening.

Pedersen JW, Gentry-Maharaj A, Nøstdal A, Fourkala EO, Dawnay A, Burnell M, Zaikin A, Burchell J, Papadimitriou JT, Clausen H, Jacobs I, Menon U, Wandall HH.

Int J Cancer. 2014 May 1;134(9):2180-88.

29.

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer.

Burford B, Gentry-Maharaj A, Graham R, Allen D, Pedersen JW, Nudelman AS, Blixt O, Fourkala EO, Bueti D, Dawnay A, Ford J, Desai R, David L, Trinder P, Acres B, Schwientek T, Gammerman A, Reis CA, Silva L, Osório H, Hallett R, Wandall HH, Mandel U, Hollingsworth MA, Jacobs I, Fentiman I, Clausen H, Taylor-Papadimitriou J, Menon U, Burchell JM.

Br J Cancer. 2013 May 28;108(10):2045-55. doi: 10.1038/bjc.2013.214. Epub 2013 May 7.

30.

Regulator of G-protein signaling 5 controls blood pressure homeostasis and vessel wall remodeling.

Holobotovskyy V, Manzur M, Tare M, Burchell J, Bolitho E, Viola H, Hool LC, Arnolda LF, McKitrick DJ, Ganss R.

Circ Res. 2013 Mar 1;112(5):781-91. doi: 10.1161/CIRCRESAHA.111.300142. Epub 2013 Jan 9.

31.

Cyclooxygenase-2 enzyme induces the expression of the α-2,3-sialyltransferase-3 (ST3Gal-I) in breast cancer.

Sproviero D, Julien S, Burford B, Taylor-Papadimitriou J, Burchell JM.

J Biol Chem. 2012 Dec 28;287(53):44490-7. doi: 10.1074/jbc.M112.427827.

32.

Evidence of recombination and positive selection in cetacean papillomaviruses.

Robles-Sikisaka R, Rivera R, Nollens HH, St Leger J, Durden WN, Stolen M, Burchell J, Wellehan JF Jr.

Virology. 2012 Jun 5;427(2):189-97. doi: 10.1016/j.virol.2012.01.039. Epub 2012 Mar 3.

33.

Expression of recombinant multi-coloured fluorescent antibodies in gor -/trxB- E. coli cytoplasm.

Markiv A, Beatson R, Burchell J, Durvasula RV, Kang AS.

BMC Biotechnol. 2011 Nov 30;11:117. doi: 10.1186/1472-6750-11-117.

34.

Selectin ligand sialyl-Lewis x antigen drives metastasis of hormone-dependent breast cancers.

Julien S, Ivetic A, Grigoriadis A, QiZe D, Burford B, Sproviero D, Picco G, Gillett C, Papp SL, Schaffer L, Tutt A, Taylor-Papadimitriou J, Pinder SE, Burchell JM.

Cancer Res. 2011 Dec 15;71(24):7683-93. doi: 10.1158/0008-5472.CAN-11-1139. Epub 2011 Oct 24.

35.

Restricted aeroallergen access to airway mucosal dendritic cells in vivo limits allergen-specific CD4+ T cell proliferation during the induction of inhalation tolerance.

Fear VS, Burchell JT, Lai SP, Wikstrom ME, Blank F, von Garnier C, Turner DJ, Sly PD, Holt PG, Strickland DS, Stumbles PA.

J Immunol. 2011 Nov 1;187(9):4561-70. doi: 10.4049/jimmunol.1004189. Epub 2011 Sep 19.

36.

Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.

Pinto R, Carvalho AS, Conze T, Magalhães A, Picco G, Burchell JM, Taylor-Papadimitriou J, Reis CA, Almeida R, Mandel U, Clausen H, Söderberg O, David L.

J Cell Mol Med. 2012 Jul;16(7):1474-84. doi: 10.1111/j.1582-4934.2011.01436.x.

37.

ST6GalNAc-I controls expression of sialyl-Tn antigen in gastrointestinal tissues.

Marcos NT, Bennett EP, Gomes J, Magalhaes A, Gomes C, David L, Dar I, Jeanneau C, DeFrees S, Krustrup D, Vogel LK, Kure EH, Burchell J, Taylor-Papadimitriou J, Clausen H, Mandel U, Reis CA.

Front Biosci (Elite Ed). 2011 Jun 1;3:1443-55.

PMID:
21622148
38.

Transforming growth factor-β1 is constitutively secreted by Chinese hamster ovary cells and is functional in human cells.

Beatson R, Sproviero D, Maher J, Wilkie S, Taylor-Papadimitriou J, Burchell JM.

Biotechnol Bioeng. 2011 Nov;108(11):2759-64. doi: 10.1002/bit.23217. Epub 2011 Jun 9.

PMID:
21618471
39.

Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.

Blixt O, Bueti D, Burford B, Allen D, Julien S, Hollingsworth M, Gammerman A, Fentiman I, Taylor-Papadimitriou J, Burchell JM.

Breast Cancer Res. 2011 Mar 8;13(2):R25. doi: 10.1186/bcr2841.

40.

PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells.

Catchpole S, Spencer-Dene B, Hall D, Santangelo S, Rosewell I, Guenatri M, Beatson R, Scibetta AG, Burchell JM, Taylor-Papadimitriou J.

Int J Oncol. 2011 May;38(5):1267-77. doi: 10.3892/ijo.2011.956. Epub 2011 Feb 28.

PMID:
21369698
41.

T cells reactive with HLA-A*0201 peptides from the histone demethylase JARID1B are found in the circulation of breast cancer patients.

Coleman JA, Correa I, Cooper L, Bohnenkamp HR, Poulsom R, Burchell JM, Taylor-Papadimitriou J.

Int J Cancer. 2011 May 1;128(9):2114-24. doi: 10.1002/ijc.25792. Epub 2011 Feb 11.

42.

MUC1 immunotherapy.

Beatson RE, Taylor-Papadimitriou J, Burchell JM.

Immunotherapy. 2010 May;2(3):305-27. doi: 10.2217/imt.10.17. Review.

PMID:
20635898
43.

Tumour-associated carbohydrate antigens in breast cancer.

Cazet A, Julien S, Bobowski M, Burchell J, Delannoy P.

Breast Cancer Res. 2010;12(3):204. doi: 10.1186/bcr2577. Epub 2010 Jun 8. Review.

44.

Over-expression of ST3Gal-I promotes mammary tumorigenesis.

Picco G, Julien S, Brockhausen I, Beatson R, Antonopoulos A, Haslam S, Mandel U, Dell A, Pinder S, Taylor-Papadimitriou J, Burchell J.

Glycobiology. 2010 Oct;20(10):1241-50. doi: 10.1093/glycob/cwq085. Epub 2010 Jun 8.

45.

UV inhibits allergic airways disease in mice by reducing effector CD4 T cells.

McGlade JP, Strickland DH, Lambert MJ, Gorman S, Thomas JA, Judge MA, Burchell JT, Zosky GR, Hart PH.

Clin Exp Allergy. 2010 May;40(5):772-85. doi: 10.1111/j.1365-2222.2010.03469.x. Epub 2010 Mar 4.

PMID:
20214669
46.

Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes.

Wandall HH, Blixt O, Tarp MA, Pedersen JW, Bennett EP, Mandel U, Ragupathi G, Livingston PO, Hollingsworth MA, Taylor-Papadimitriou J, Burchell J, Clausen H.

Cancer Res. 2010 Feb 15;70(4):1306-13. doi: 10.1158/0008-5472.CAN-09-2893. Epub 2010 Feb 2.

47.

1,25-dihydroxyvitamin D3 enhances the ability of transferred CD4+ CD25+ cells to modulate T helper type 2-driven asthmatic responses.

Gorman S, Judge MA, Burchell JT, Turner DJ, Hart PH.

Immunology. 2010 Jun;130(2):181-92. doi: 10.1111/j.1365-2567.2009.03222.x. Epub 2010 Jan 6.

48.

The role of dendritic cells and regulatory T cells in the regulation of allergic asthma.

Burchell JT, Strickland DH, Stumbles PA.

Pharmacol Ther. 2010 Jan;125(1):1-10. doi: 10.1016/j.pharmthera.2009.06.015. Epub 2009 Aug 15. Review.

PMID:
19686776
49.

Airway hyperresponsiveness is associated with activated CD4+ T cells in the airways.

Zosky GR, Larcombe AN, White OJ, Burchell JT, von Garnier C, Holt PG, Turner DJ, Wikstrom ME, Sly PD, Stumbles PA.

Am J Physiol Lung Cell Mol Physiol. 2009 Aug;297(2):L373-9. doi: 10.1152/ajplung.00053.2009. Epub 2009 May 29.

50.

Sialyl-Tn vaccine induces antibody-mediated tumour protection in a relevant murine model.

Julien S, Picco G, Sewell R, Vercoutter-Edouart AS, Tarp M, Miles D, Clausen H, Taylor-Papadimitriou J, Burchell JM.

Br J Cancer. 2009 Jun 2;100(11):1746-54. doi: 10.1038/sj.bjc.6605083. Epub 2009 May 12.

Supplemental Content

Loading ...
Support Center